Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

17 Dec 2013 10:27

RNS Number : 7323V
Omega Diagnostics Group PLC
17 December 2013
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Omega Diagnostics Group plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Octopus Investments Nominees Limited

4. Full name of shareholder(s)  (if different from 3.):iv

n/a

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

13/12/2013

6. Date on which issuer notified:

17/12/2013

7. Threshold(s) that is/are crossed orreached: vi, vii

 7%

 

8. Notified details: n/a

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00B1VCP282

7669650

7669650

7469650

7469650

6.87%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

7469650

6.87%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

n/a

Proxy Voting:

10. Name of the proxy holder:

n/a

11. Number of voting rights proxy holder will ceaseto hold:

n/a

12. Date on which proxy holder will cease to holdvoting rights:

n/a

13. Additional information:

14. Contact name:

Niki Read

15. Contact telephone number:

020 7776 7969

 

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

Peter Orsi

Contact address

(registered office for legal entities)

 

20 Old Bailey, London, EC4M 7AN

Phone number & email

 

020 7710 2877

Other useful information

(at least legal representative for legal persons)

 

B: Identity of the notifier, if applicable

Full name

 

Contact address

 

Phone number & email

 

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUBURROVAUAAA
Date   Source Headline
9th Oct 20097:00 amRNSTrading Update
2nd Oct 20093:20 pmRNSHolding(s) in Company
2nd Oct 20093:04 pmRNSHolding(s) in Company
2nd Oct 200912:16 pmRNSHolding(s) in Company
2nd Oct 20098:53 amRNSHolding(s) in Company
30th Sep 20097:00 amRNSHolding(s) in Company
30th Sep 20097:00 amRNSHolding(s) in Company
25th Sep 20097:00 amRNSIssue of equity and acquisition
27th Aug 200911:56 amRNSAGM Statement
17th Jul 20099:00 amRNSAnnual Financial Report
16th Jul 20097:00 amRNSUK Distribution agreement for Genesis products
7th Jul 20097:00 amRNSFinal Results
4th Jun 20097:00 amRNSHolding(s) in Company
26th May 20097:00 amRNSLaunch of quality performance product
6th Apr 20093:03 pmRNSDirector/PDMR Shareholding
2nd Apr 200911:41 amRNSTrading Statement
20th Mar 20092:00 pmRNSChange of Adviser
12th Dec 20083:48 pmRNSDirector/PDMR Shareholding
27th Nov 20087:00 amRNSInterim Results
11th Nov 20087:00 amRNSTrading Statement
8th Oct 20083:57 pmRNSChange of Adviser Name
28th Aug 20081:24 pmRNSAGM Statement
12th Aug 200810:51 amRNSIssue of Equity / Directors'
18th Jul 200811:30 amRNSAnnual Report and Accounts
7th Jul 20087:00 amRNSFinal Results
12th Jun 20087:00 amRNSNotice of Results
10th Apr 20087:18 amRNSTrading Statement
12th Mar 200811:59 amRNSDirector/PDMR Shareholding
11th Mar 20082:19 pmRNSDirector/PDMR Shareholding
4th Mar 20087:01 amRNSDirector/PDMR Shareholding
10th Jan 20082:28 pmRNSHolding(s) in Company
7th Dec 20077:01 amRNSInterim Results
28th Sep 20077:01 amRNSTotal Voting Rights
26th Sep 20077:01 amRNSNotifiable Interest
3rd Sep 20078:00 amRNSCompletion of Acquisition
3rd Sep 20078:00 amRNSTotal Voting Rights
31st Aug 20071:27 pmRNSDirectors' Dealings
31st Aug 20078:21 amRNSGenesis-CNS Interim Results
31st Aug 20078:00 amRNSCancellation - 31/08/07
30th Aug 200712:56 pmRNSResult of EGM
15th Aug 20078:23 amRNSCompliance with AIM Rule 26
13th Aug 200710:22 amRNSSchedule 1 -Omega Diagnostics
8th Aug 200712:26 pmRNSAGM Statement
6th Aug 20077:01 amRNSAcquisition and placing
6th Aug 20077:00 amRNSRestoration-Omega Diagnostics
6th Aug 20077:00 amRNSChange of Adviser
12th Jul 20071:30 pmRNSStatement re. Suspension
12th Jul 20071:30 pmRNSSuspension-Omega Diagnostics
26th Jun 20077:01 amRNSFinal Results
18th Apr 20074:50 pmRNSAccounting Reference Date

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.